Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients
중환자 코로나바이러스 질환 2019 환자에서 뚜렷한 면역표현형 식별
Article
[키워드] Activation
Acute respiratory failure
cause
CD4+
CD8+
clinical trial
Cluster
Clustering
complement
Complement activation
conducted
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patient
Critical
Critical care
Critically ill
critically ill COVID-19 patients
cytokine
cytokine level
cytokine release
elevated
eligibility
endothelial
enrolled
evaluated
exaggerated inflammatory response
exhibiting
favor
feature
France
group
heterogeneous
Hierarchical
hierarchical clustering
Hypogammaglobulinemia
ICU
ICU admission
identification
IL-1β
IL-6
IL-8
Ill
immunodeficiency
immunologically
immunology
immunophenotype
Infection
Inflammation
inflammatory reaction
lung damage
marker
mediators
moderate
multi-organ dysfunction
Necrosis
outcomes
Patient
patient identification
patients
phenotype
predominant
principal components
principal components analysis
Profiling
Prospective Study
respiratory
Respiratory failure
response to therapies
SARS-CoV-2
SARS-COV-2 infection
SC5b-9
Severe acute respiratory syndrome
severe acute respiratory syndrome-coronavirus-2
severe COVID-19
severity
shown
single-center
targeted therapy
therapeutic
therapy
Trajectories
tumor necrosis
tumor necrosis factor
tumor necrosis factor-alpha
Variability
variable
[DOI] 10.1016/j.chest.2020.11.049 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.chest.2020.11.049 PMC 바로가기 [Article Type] Article